BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zumla A, Malon P, Henderson J, Grange JM. Impact of HIV infection on tuberculosis. Postgrad Med J 2000;76:259-68. [PMID: 10775277 DOI: 10.1136/pmj.76.895.259] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Singh P, Rawat S, Agrahari AK, Singh M, Chugh S, Gurcha S, Singh A, Abrahams K, Besra GS, Asthana S, Rawat DS, Singh R. NSC19723, a Thiacetazone-Like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs In Vitro and In Vivo. Microbiol Spectr 2022;10:e0259222. [PMID: 36314972 DOI: 10.1128/spectrum.02592-22] [Reference Citation Analysis]
2 Heffernan C, Haworth-brockman M, Plourde P, Wong T, Ferrara G, Long R. Chapter 15: Monitoring tuberculosis program performance. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:229-241. [DOI: 10.1080/24745332.2022.2035123] [Reference Citation Analysis]
3 Ibrahim MN, Nik Husain NR, Daud A, Chinnayah T. Epidemiology and Risk Factors of Delayed Sputum Smear Conversion in Malaysian Aborigines with Smear-Positive Pulmonary Tuberculosis. Int J Environ Res Public Health 2022;19:2365. [PMID: 35206552 DOI: 10.3390/ijerph19042365] [Reference Citation Analysis]
4 Chakroun M, Kooli I, Marrakchi W, Brahim HB, Aouam A, Toumi A. Tuberculosis and Human Immunodeficiency Virus Co-infection. Imaging of Tuberculosis 2022. [DOI: 10.1007/978-3-031-07040-2_14] [Reference Citation Analysis]
5 How GY, Leow KS, Ooi ST, Peh WCG. Diagnostic Algorithm of Tuberculosis. Imaging of Tuberculosis 2022. [DOI: 10.1007/978-3-031-07040-2_15] [Reference Citation Analysis]
6 Zare S, Kabiri M, Amini Y, Najafi A, Mohammadpour F, Ayati SH, Nikpoor AR, Tafaghodi M. Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis. AAPS PharmSciTech 2021;23:15. [PMID: 34893923 DOI: 10.1208/s12249-021-02146-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Montes K, Atluri H, Silvestre Tuch H, Ramirez L, Paiz J, Hesse Lopez A, Bailey TC, Spec A, Mejia-Chew C. Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting. J Clin Tuberc Other Mycobact Dis 2021;25:100287. [PMID: 34849409 DOI: 10.1016/j.jctube.2021.100287] [Reference Citation Analysis]
8 Devalraju KP, Tripathi D, Neela VSK, Paidipally P, Radhakrishnan RK, Singh KP, Ansari MS, Jaeger M, Netea-Maier RT, Netea MG, Park S, Cheng SY, Valluri VL, Vankayalapati R. Reduced thyroxine production in young household contacts of tuberculosis patients increases active tuberculosis disease risk. JCI Insight 2021;6:148271. [PMID: 34236051 DOI: 10.1172/jci.insight.148271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kumari M, Rafia, Rajeev A, Shree R, Khan A, Niraj LK. Prevalence of Tuberculosis among Human Immunodeficiency Virus-Positive Patients – A Cross-sectional Study. JRAD 2021;12:232-234. [DOI: 10.53064/jrad.2021.12.5.55] [Reference Citation Analysis]
10 Sergeeva M, Romanovskaya-Romanko E, Zabolotnyh N, Pulkina A, Vasilyev K, Shurigina AP, Buzitskaya J, Zabrodskaya Y, Fadeev A, Vasin A, Vinogradova TI, Stukova MA. Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs. Vaccines (Basel) 2021;9:394. [PMID: 33923548 DOI: 10.3390/vaccines9040394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Charoensakulchai S, Lertpheantum C, Aksornpusitpong C, Trakulsuk P, Sakboonyarat B, Rangsin R, Mungthin M, Piyaraj P. Six-year trend and risk factors of unsuccessful pulmonary tuberculosis treatment outcomes in Thai Community Hospital. BMC Res Notes 2021;14:89. [PMID: 33750450 DOI: 10.1186/s13104-021-05504-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Shimonovich M, Pearce A, Thomson H, Keyes K, Katikireddi SV. Assessing causality in epidemiology: revisiting Bradford Hill to incorporate developments in causal thinking. Eur J Epidemiol 2021;36:873-87. [PMID: 33324996 DOI: 10.1007/s10654-020-00703-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
13 González Fernández L, Casas EC, Singh S, Churchyard GJ, Brigden G, Gotuzzo E, Vandevelde W, Sahu S, Ahmedov S, Kamarulzaman A, Ponce-de-León A, Grinsztejn B, Swindells S. New opportunities in tuberculosis prevention: implications for people living with HIV. J Int AIDS Soc 2020;23:e25438. [PMID: 31913556 DOI: 10.1002/jia2.25438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
14 Spekker O, Schultz M, Paja L, Váradi OA, Molnár E, Pálfi G, Hunt DR. Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitis. PLoS One 2020;15:e0238444. [PMID: 32870917 DOI: 10.1371/journal.pone.0238444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Bongongo T, Van der Heever H, Nzaumvila DK, Saidiya CNS. Influence of patients' living conditions on tuberculosis treatment outcomes in a South African health sub-district. S Afr Fam Pract (2004) 2020;62:e1-6. [PMID: 32896141 DOI: 10.4102/safp.v62i1.5036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Dhar M, Samaddar S, Bhattacharya P. Modeling the cell-to-cell transmission dynamics of viral infection under the exposure of non-cytolytic cure. J Appl Math Comput 2021;65:885-911. [DOI: 10.1007/s12190-020-01420-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hao X, Lou H, Bai J, Ding Y, Yang J, Pan W. Cost-effectiveness analysis of Xpert in detecting Mycobacterium tuberculosis: A systematic review. Int J Infect Dis 2020;95:98-105. [PMID: 32278935 DOI: 10.1016/j.ijid.2020.03.078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Canetti D, Riccardi N, Martini M, Villa S, Di Biagio A, Codecasa L, Castagna A, Barberis I, Gazzaniga V, Besozzi G. HIV and tuberculosis: The paradox of dual illnesses and the challenges of their fighting in the history. Tuberculosis (Edinb) 2020;122:101921. [PMID: 32501257 DOI: 10.1016/j.tube.2020.101921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
19 Negash H, Legese H, Adhanom G, Mardu F, Tesfay K, Gebreslasie Gebremeskel S, Berhe B. Six Years Trend Analysis of Tuberculosis in Northwestern Tigrai, Ethiopia; 2019: A Retrospective Study. Infect Drug Resist 2020;13:643-9. [PMID: 32158240 DOI: 10.2147/IDR.S239717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Atey TM, Bitew H, Asgedom SW, Endrias A, Berhe DF. Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study. AIDS Res Treat 2020;2020:7025738. [PMID: 32411454 DOI: 10.1155/2020/7025738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Călărașu C, Niţu M, Olteanu M, Golli AL, Dumitrescu F, Olteanu M. Pulmonary tuberculosis with atypical presentation because of unknown previous HIV infection – case report. Pneumologia 2019;68:41-5. [DOI: 10.2478/pneum-2019-0011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Cresswell FV, Te Brake L, Atherton R, Ruslami R, Dooley KE, Aarnoutse R, Van Crevel R. Intensified antibiotic treatment of tuberculosis meningitis. Expert Rev Clin Pharmacol 2019;12:267-88. [PMID: 30474434 DOI: 10.1080/17512433.2019.1552831] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
23 Teweldemedhin M, Asres N, Gebreyesus H, Asgedom SW. Tuberculosis-Human Immunodeficiency Virus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis 2018;18:676. [PMID: 30563476 DOI: 10.1186/s12879-018-3604-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
24 Peters JS, Andrews JR, Hatherill M, Hermans S, Martinez L, Schurr E, van der Heijden Y, Wood R, Rustomjee R, Kana BD. Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings. Lancet Infect Dis 2019;19:e65-76. [PMID: 30554995 DOI: 10.1016/S1473-3099(18)30477-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
25 Mohan A, Harikrishna J, Kumar DP, Kumar ND, Sharma PS, Kumar BS, Sarma KVS. Provider-initiated HIV testing & counselling in incident tuberculosis cases under National TB Programme conditions at a tertiary care teaching hospital in Tirupati, south India. Indian J Med Res 2017;146:774-9. [PMID: 29664037 DOI: 10.4103/ijmr.IJMR_639_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Hayward S, Harding RM, McShane H, Tanner R. Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK. F1000Res 2018;7:461. [PMID: 30210785 DOI: 10.12688/f1000research.14476.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
27 Hayward S, Harding RM, McShane H, Tanner R. Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK. F1000Res 2018;7:461. [PMID: 30210785 DOI: 10.12688/f1000research.14476.2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
28 Takhar RP, Mirdha K, Purohit G, Maan L, Bainara MK. Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression. Tanaffos 2018;17:188-97. [PMID: 30915136] [Reference Citation Analysis]
29 Rosser A, Richardson M, Wiselka MJ, Free RC, Woltmann G, Mukamolova GV, Pareek M. A nested case-control study of predictors for tuberculosis recurrence in a large UK Centre. BMC Infect Dis 2018;18:94. [PMID: 29486715 DOI: 10.1186/s12879-017-2933-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
30 Bloomfield GS, Leung C. Cardiac Disease Associated with Human Immunodeficiency Virus Infection. Cardiol Clin 2017;35:59-70. [PMID: 27886790 DOI: 10.1016/j.ccl.2016.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
31 Tiberi S, Carvalho AC, Sulis G, Vaghela D, Rendon A, Mello FC, Rahman A, Matin N, Zumla A, Pontali E. The cursed duet today: Tuberculosis and HIV-coinfection. Presse Med 2017;46:e23-39. [PMID: 28256380 DOI: 10.1016/j.lpm.2017.01.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
32 Rishi P, Rishi E, Nair S, Sudharshan S, Abraham S. Ocular Tuberculosis in Immunocompromised Patients. Essentials in Ophthalmology 2017. [DOI: 10.1007/978-3-319-57520-9_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Grobler L, Nagpal S, Sudarsanam TD, Sinclair D. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2016;:CD006086. [PMID: 27355911 DOI: 10.1002/14651858.CD006086.pub4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
34 Xia Q, Westenhouse JL, Schultz AF, Nonoyama A, Elms W, Wu N, Tabshouri L, Ruiz JD, Flood JM. Matching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California. Health Informatics J 2011;17:41-50. [PMID: 25133769 DOI: 10.1177/1460458210380524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
35 Sharma SK, Mohan A, Sharma A. Miliary tuberculosis: A new look at an old foe. J Clin Tuberc Other Mycobact Dis 2016;3:13-27. [PMID: 31723681 DOI: 10.1016/j.jctube.2016.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
36 Trinh QM, Nguyen HL, Nguyen VN, Nguyen TV, Sintchenko V, Marais BJ. Tuberculosis and HIV co-infection-focus on the Asia-Pacific region. Int J Infect Dis 2015;32:170-8. [PMID: 25809776 DOI: 10.1016/j.ijid.2014.11.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
37 Mwacalimba K. Disease Control, Public Health and Food Safety: Food Policy Lessons from Sub-Saharan Africa. International Food Law and Policy 2016. [DOI: 10.1007/978-3-319-07542-6_42] [Reference Citation Analysis]
38 Li Y, Li H, Lv F. Disseminated tuberculosis in a patient with AIDS on F-18 FDG PET/CT. Radiology of Infectious Diseases 2015;2:192-196. [DOI: 10.1016/j.jrid.2015.11.009] [Reference Citation Analysis]
39 Edessa D, Likisa J. A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study. PLoS One 2015;10:e0137492. [PMID: 26348618 DOI: 10.1371/journal.pone.0137492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
40 Nduba V, Hoog AH, Mitchell E, Onyango P, Laserson K, Borgdorff M. Prevalence of tuberculosis in adolescents, western Kenya: implications for control programs. Int J Infect Dis 2015;35:11-7. [PMID: 25770911 DOI: 10.1016/j.ijid.2015.03.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
41 Li H. Functional Imaging of HIV/AIDS. Radiology of HIV/AIDS 2014. [DOI: 10.1007/978-94-007-7823-8_26] [Reference Citation Analysis]
42 Sharma SK, Soneja M, Prasad KT, Ranjan S. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India. Indian J Med Res 2014;139:154-60. [PMID: 24604050] [Reference Citation Analysis]
43 Sudjaritruk T, Maleesatharn A, Prasitsuebsai W, Fong SM, Le NO, Le TT, Lumbiganon P, Kumarasamy N, Kurniati N, Hansudewechakul R, Yusoff NK, Razali KA, Kariminia A, Sohn AH, Sirisanthana V; TREAT Asia Pediatric HIV Observational Database. Prevalence, characteristics, management, and outcome of pulmonary tuberculosis in HIV-infected children in the TREAT Asia pediatric HIV Observational Database (TApHOD). AIDS Patient Care STDS 2013;27:649-56. [PMID: 24206012 DOI: 10.1089/apc.2013.0236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
44 Bogle SR, B NG, Sharma VK, Dave L. STUDY OF SEROPREVALENCE OF HIV AMONG TUBERCULOSIS PATIENTS AND CLINICO- RADIOLOGICAL IMPLICATIONS OF DUAL INFECTIONS. jemds 2013;2:4966-4973. [DOI: 10.14260/jemds/938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Wang Q, Lei C, Liu Q. Ub Combination Enhanced Cellular Immune Response Elicited by HSP65 DNA Vaccine against <i>Mycobacterium tuberculosis</i>. WJV 2013;03:89-97. [DOI: 10.4236/wjv.2013.33013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Mehta S, Banker AS, Chauhan R. Retinal and Choroidal Manifestations of Tuberculosis. Retinal and Choroidal Manifestations of Selected Systemic Diseases 2013. [DOI: 10.1007/978-1-4614-3646-1_5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Wondimeneh Y, Muluye D, Belyhun Y. Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes 2012;5:331. [PMID: 22738361 DOI: 10.1186/1756-0500-5-331] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
48 Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res 2012;135:703-30. [PMID: 22771605] [Reference Citation Analysis]
49 Crofts JP, Kruijshaar ME, Delpech V, Ncube F, Abubakar I. Tuberculosis and HIV co-infection in healthcare workers in England and Wales, 1999–2005. Epidemiol Infect 2012;140:1873-9. [DOI: 10.1017/s0950268811002445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Sinclair D, Abba K, Grobler L, Sudarsanam TD. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2011;:CD006086. [PMID: 22071828 DOI: 10.1002/14651858.CD006086.pub3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 64] [Article Influence: 2.8] [Reference Citation Analysis]
51 Echejoh GO, Tanko MN, Manasseh AN, Ogala-echejoh S, Mandong B, Okeke E. HIV/TB co-infection: Liver biopsy findings. Clinical and Experimental Medical Journal 2011;5:135-141. [DOI: 10.1556/cemed.5.2011.2.8] [Reference Citation Analysis]
52 Tessema TA, Bjune G, Assefa G, Svenson S, Hamasur B, Bjorvatn B. Clinical and Radiological Features in Relation to Urinary Excretion of Lipoarabinomannan in Ethiopian Tuberculosis Patients. Scandinavian Journal of Infectious Diseases 2009;34:167-71. [DOI: 10.1080/00365540110077254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
53 Mehta S, Gilada IS. CASE REPORT Ocular Tuberculosis in Acquired Immune Deficiency Syndrome (AIDS). Ocular Immunology and Inflammation 2009;13:87-9. [DOI: 10.1080/09273940490518702] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
54 Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T, Melaku Z, Mengistu Y, Lemma E, Wells CD, Wuhib T, Nelson LJ. Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 2009;50:537-45. [PMID: 19223783 DOI: 10.1097/QAI.0b013e318196761c] [Cited by in Crossref: 42] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
55 Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009;9:173-84. [PMID: 19246021 DOI: 10.1016/S1473-3099(09)70043-X] [Cited by in Crossref: 157] [Cited by in F6Publishing: 159] [Article Influence: 11.2] [Reference Citation Analysis]
56 Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene. Tuberculosis 2009;89:54-61. [DOI: 10.1016/j.tube.2008.09.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
57 Georgiev VS. Tuberculosis. National Institute of Allergy and Infectious Diseases, NIH 2009. [DOI: 10.1007/978-1-60327-297-1_14] [Reference Citation Analysis]
58 García-Zamalloa AM, Arrizabalaga J. [Tuberculosis in the Bajo Deba area (Guipúzcoa, Spain) from 1995 to 2006]. Enferm Infecc Microbiol Clin 2008;26:187-93. [PMID: 18381037 DOI: 10.1016/s0213-005x(08)72689-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
59 Abba K, Sudarsanam TD, Grobler L, Volmink J. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2008;:CD006086. [PMID: 18843702 DOI: 10.1002/14651858.CD006086.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
60 Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, Volmink JA, Mayosi BM. HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study. PLoS One 2008;3:e2253. [PMID: 18523576 DOI: 10.1371/journal.pone.0002253] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
61 Schumann A, Nyamathi A, Stein JA. HIV risk reduction in a nurse case-managed TB and HIV intervention among homeless adults. J Health Psychol 2007;12:833-43. [PMID: 17855466 DOI: 10.1177/1359105307080618] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
62 &NA;. Clinical Watch. Journal of the American Academy of Physician Assistants 2008;21:23. [DOI: 10.1097/01720610-200801000-00006] [Reference Citation Analysis]
63 Syed FF, Mayosi BM. A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis. 2007;50:218-236. [PMID: 17976506 DOI: 10.1016/j.pcad.2007.03.002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 103] [Article Influence: 5.6] [Reference Citation Analysis]
64 Pandey V, Chawla K, Acharya K, Rao S, Rao S. The role of polymerase chain reaction in the management of osteoarticular tuberculosis. Int Orthop 2009;33:801-5. [PMID: 18038134 DOI: 10.1007/s00264-007-0485-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
65 Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 2007;93:1176-83. [PMID: 17890693 DOI: 10.1136/hrt.2007.127746] [Cited by in Crossref: 127] [Cited by in F6Publishing: 148] [Article Influence: 7.9] [Reference Citation Analysis]
66 Mwandumba HC, Bertel Squire S, White SA, Nyirenda MH, Kampondeni SD, Rhoades ER, Zijlstra EE, Molyneux ME, Russell DG. Association between sputum smear status and local immune responses at the site of disease in HIV-infected patients with pulmonary tuberculosis. Tuberculosis (Edinb) 2008;88:58-63. [PMID: 17913585 DOI: 10.1016/j.tube.2007.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
67 Vermund SH, Yamamoto N. Co-infection with human immunodeficiency virus and tuberculosis in Asia. Tuberculosis (Edinb) 2007;87 Suppl 1:S18-25. [PMID: 17631414 DOI: 10.1016/j.tube.2007.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
68 Achkar JM, Casadevall A, Glatman-Freedman A. Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches. Expert Rev Anti Infect Ther 2007;5:461-74. [PMID: 17547510 DOI: 10.1586/14787210.5.3.461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
69 Gupta UD, Katoch VM, McMurray DN. Current status of TB vaccines. Vaccine 2007;25:3742-51. [PMID: 17321015 DOI: 10.1016/j.vaccine.2007.01.112] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.3] [Reference Citation Analysis]
70 Derrick SC, Morris SL. The ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression. Cell Microbiol 2007;9:1547-55. [PMID: 17298391 DOI: 10.1111/j.1462-5822.2007.00892.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 164] [Article Influence: 9.7] [Reference Citation Analysis]
71 Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608-3616. [PMID: 16330703 DOI: 10.1161/circulationaha.105.543066] [Cited by in Crossref: 275] [Cited by in F6Publishing: 299] [Article Influence: 16.2] [Reference Citation Analysis]
72 Singh KK, Dong Y, Belisle JT, Harder J, Arora VK, Laal S. Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis. Clin Diagn Lab Immunol 2005;12:354-8. [PMID: 15699433 DOI: 10.1128/CDLI.12.2.354-358.2005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
73 Derrick SC, Yang AL, Morris SL. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 2004;23:780-8. [PMID: 15542202 DOI: 10.1016/j.vaccine.2004.07.036] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 3.9] [Reference Citation Analysis]
74 Buckingham S, Haddow L, Shaw P, Miller R. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clinical Radiology 2004;59:505-13. [DOI: 10.1016/j.crad.2003.12.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
75 Limaye S, Quin J, Steele RH. HIV and tuberculosis co-infection in south-western Sydney: experience from a case series: HIV/TB co-infection cases and discussion. Internal Medicine Journal 2004;34:203-6. [DOI: 10.1111/j.1444-0903.2004.00560.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
76 Van den Brande P, Vanhoenacker F, Demedts M. Tuberculosis at the beginning of the third millennium: one disease, three epidemics. Eur Radiol 2003;13:1767-70. [PMID: 12945565 DOI: 10.1007/s00330-002-1636-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
77 Britton WJ, Palendira U. Improving vaccines against tuberculosis. Immunol Cell Biol 2003;81:34-45. [PMID: 12534944 DOI: 10.1046/j.0818-9641.2002.01143.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.5] [Reference Citation Analysis]
78 Rodríguez AS. La infección tuberculosa en adultos. Revista Clínica Española 2003;203:315-316. [DOI: 10.1016/s0014-2565(03)71278-8] [Reference Citation Analysis]
79 Mankin HJ. Tuberculosis of bone and joints: the Red King lives!: . Current Opinion in Orthopaedics 2001;12:489-98. [DOI: 10.1097/00001433-200112000-00010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
80 Lodes MJ, Dillon DC, Mohamath R, Day CH, Benson DR, Reynolds LD, McNeill P, Sampaio DP, Skeiky YA, Badaro R, Persing DH, Reed SG, Houghton RL. Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen. J Clin Microbiol 2001;39:2485-93. [PMID: 11427558 DOI: 10.1128/JCM.39.7.2485-2493.2001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
81 Grange J, Story A, Zumla A. Tuberculosis in disadvantaged groups: . Current Opinion in Pulmonary Medicine 2001;7:160-4. [DOI: 10.1097/00063198-200105000-00008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
82 Pennycook A, Openshaw P, Hussell T. Partners in crime: co-infections in the developing world. Clin Exp Immunol 2000;122:296-9. [PMID: 11122231 DOI: 10.1046/j.1365-2249.2000.01407.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]